Publications by authors named "Krzysiek R"

Article Synopsis
  • HIV infection increases the risk of diffuse large B-cell lymphoma (DLBCL), and this study analyzed B-cell activating cytokines and T cell subsets in 51 HIV-associated DLBCL patients undergoing R-CHOP treatment.
  • R-CHOP therapy led to decreased IL-10 and fluctuating IL-6 levels while BAFF levels initially rose and then fell; a significant increase in naïve B cells was observed, but recovery of other B cell types was gradual.
  • With a median follow-up of 41 months, 5-year progression-free survival was 61.8% and overall survival was 67.4%, with main causes of death being disease progression and sepsis, highlighting the need for assessing B-cell disturbances in patient
View Article and Find Full Text PDF

Background: Multiple sclerosis (MS) may occur before the age of 18. Differentiation between paediatric MS (PedMS) and other demyelinating syndromes (ODSs) is challenging. In adult with MS, the kappa free light chain (KFLC) index has proven to be a reliable marker of intrathecal Ig synthesis.

View Article and Find Full Text PDF

Objectives: Given that method validation is mandatory for compliance with the International Organization for Standardization (ISO) 15,189 standard requirements, we evaluated the analytical performance of the AQUIOS CL system (Beckman Coulter) and compared it with two bead-based flow cytometry (FCM) protocols (BD FACSCAntoII and Beckman Coulter DxFLEX). There are no comparative literature data on standardized protocols for counting lymphocyte subsets on the new-generation cytometer DxFLEX.

Methods: We evaluated the AQUIOS CL's performance with regard to accuracy, linearity and stability by using dedicated control cell samples and patient samples.

View Article and Find Full Text PDF
Article Synopsis
  • The study assesses the new i-TRACK chemiluminescent instrument for monitoring biological TNF inhibitors in patients, comparing its performance to traditional ELISA methods in gastroenterology.
  • Intra- and inter-run performance metrics were found to be satisfactory, with i-TRACK often yielding higher values for drug and antibody measurements compared to manual ELISA.
  • While i-TRACK shows potential for routine use due to its rapidity and usability, it is recommended to use the same assay consistently in patient follow-ups due to some discrepancies in quantitative results.
View Article and Find Full Text PDF

Classical Hodgkin Lymphoma incidence increases in HIV-1-infected patients (HIV-cHL). HIV infection is associated with higher B-cell activation. Here, in 38 HIV-cHL patients from the French cohort ANRS-CO16 Lymphovir, we examined longitudinally over 24 months the serum levels of the B-cell activating cytokines IL10, IL6, and BAFF, and blood distribution of B-cell subsets.

View Article and Find Full Text PDF
Article Synopsis
  • The study investigates the risk of lymphoma in rheumatoid arthritis patients receiving different types of tumor necrosis factor inhibitors (TNFi), focusing on monoclonal anti-TNF antibodies versus soluble TNF receptors.
  • Using a mouse model of autoimmunity, researchers found that prolonged treatment with monoclonal anti-TNF antibodies significantly increased lymphoma risk compared to control groups and those treated with soluble TNF receptors.
  • Results indicate lower splenic macrophage infiltration in the monoclonal antibody group, suggesting the need for careful monitoring of lymphoma development in patients with B cell-driven autoimmune diseases undergoing long-term treatment with these antibodies.
View Article and Find Full Text PDF

Objectives: Obinutuzumab (OBZ) is a new humanised type II anti-CD20 monoclonal antibody (mAb) approved in onco-haematology. Its use as an alternative to rituximab (RTX) in case of immunisation in autoimmune diseases has not been fully assessed yet. Here we report the case of a patient suffering from a refractory cryoglobulinaemic vasculitis (CV) associated to Sjögren's syndrome (SS) and treated with OBZ.

View Article and Find Full Text PDF

Peripheral lymphopenia is a well-known negative prognostic marker in classical Hodgkin lymphoma (cHL). We characterized the peripheral B-cell compartment in a prospective cohort of 83 pediatric cHL patients. We observed significantly low total B-cell counts (<100 cells/µl) in 31 of 83 patients (37%).

View Article and Find Full Text PDF

Psychological distress has long been suspected to influence cancer incidence and mortality. It remains largely unknown whether and how stress affects the efficacy of anticancer therapies. We observed that social defeat caused anxiety-like behaviors in mice and dampened therapeutic responses against carcinogen-induced neoplasias and transplantable tumors.

View Article and Find Full Text PDF

Objective: To investigate the relationship of clinical response of Juvenile Idiopathic Arthritis (JIA) to etanercept (ETN) with ETN levels, and the presence of anti-drug antibodies to ETN (ADAb).

Methods: Prospective study of JIA patients under 18 years old. Clinical and pharmacological data were collected at two visits.

View Article and Find Full Text PDF

Calcium (Ca ) signaling controls T-cell activation and functions. Ca concentrations are locally detected and controlled by Ca -sensors (STIM1 and 2 detecting the depletion from ER stores channels) and Ca -channels (ORAI1-3 in the cell membrane and VDAC1 in the outer mitochondrial membrane). We first validated and titrated antibodies to assess the expression of these Ca -sensors and -channels in human and murine cells, and further devised a 18-antibodies mass cytometry panel to characterize their expression in primary murine lymphocyte subsets.

View Article and Find Full Text PDF

Objectives: TNF inhibitors (TNFi) can induce anti-drug antibodies (ADA) in patients with autoimmune diseases (AID) leading to clinical resistance. We explored a new way of using methotrexate (MTX) to decrease this risk of immunisation.

Methods: We treated BAFF transgenic (BAFFtg) mice, a model of AID in which immunisation against biologic drugs is high, with different TNFi.

View Article and Find Full Text PDF

Objective: The immunogenicity of tocilizumab (TCZ) has been poorly studied. We assessed the immunogenicity of TCZ and serum TCZ trough levels in rheumatoid arthritis (RA) patients and the preexisting TCZ-specific CD4+ T cell repertoire in healthy controls.

Methods: Anti-drug antibodies (ADAs) to TCZ and serum TCZ trough levels in RA patients were assessed at different times by ELISA.

View Article and Find Full Text PDF

In patients who are receiving prolonged antiretroviral treatment (ART), HIV can persist within a small pool of long-lived resting memory CD4(+) T cells infected with integrated latent virus. This latent reservoir involves distinct memory subsets. Here we provide results that suggest a progressive reduction of the size of the blood latent reservoir around a core of less-differentiated memory subsets (central memory and stem cell-like memory (TSCM) CD4(+) T cells).

View Article and Find Full Text PDF

Tolerance induction by dendritic cells (DCs) is, in part, mediated by the activation of regulatory T cells (Tregs). We have previously shown in vitro that human DCs treated with glucocorticoids (GCs), IL-10, or TGF-β upregulate the GC-Induced Leucine Zipper protein (GILZ). GILZ overexpression promotes DC differentiation into regulatory cells that generate IL-10-producing Ag-specific Tregs.

View Article and Find Full Text PDF

T cell immunity is characterized by striking tissue specialization. Tissue-specificity imprinting starts during priming by tissue-derived migratory dendritic cells in the non-random, specialized micro-anatomical area of the draining lymph node and is influenced by constitutive and induced cues from local environment. Besides tissue-specific effectors, memory cells also exhibit a tissue-specificity.

View Article and Find Full Text PDF

The therapeutic efficacy of anthracyclines relies on antitumor immune responses elicited by dying cancer cells. How chemotherapy-induced cell death leads to efficient antigen presentation to T cells, however, remains a conundrum. We found that intratumoral CD11c(+)CD11b(+)Ly6C(hi) cells, which displayed some characteristics of inflammatory dendritic cells and included granulomonocytic precursors, were crucial for anthracycline-induced anticancer immune responses.

View Article and Find Full Text PDF

Background: Infliximab is effective for the treatment of refractory inflammatory bowel disease (IBD). Nevertheless, up to 40% of patients lose response to infliximab over time. The aim was to assess the clinical value of measuring infliximab trough levels and antibodies to infliximab (ATI) concentrations in IBD patients who lost response to infliximab therapy.

View Article and Find Full Text PDF

The use of TNF-α antagonists has substantially improved the care of many patients with inflammatory and autoimmune diseases. However, approximately one third of such patients fail to respond well to treatment, regardless of the antagonist used or of the underlying disease. The mechanisms underlying these failures are analyzed in this review, and proposals made concerning how best to adapt therapeutic decisions in these instances.

View Article and Find Full Text PDF

Dendritic cells (DCs) play a crucial role in T cell allorecognition in the context of organ transplantation and allogeneic hematopoietic stem cell transplantation (allo-HSCT). This DC function is believed to be directly involved in allo-HSCT morbidity and mortality. DC functions range from immunoaggressive responses to the promotion of tolerance, reflecting functional plasticity.

View Article and Find Full Text PDF